We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Rise in AUM to Aid BNY Mellon's (BK) Q1 Earnings Amid Low Rates
Read MoreHide Full Article
The Bank of New York Mellon Corporation (BK - Free Report) is scheduled to report first-quarter 2021 results on Apr 16, before market open. Its revenues and earnings in the to-be-reported quarter are expected to have witnessed a decline on a year-over-year basis.
In the last reported quarter, the company’s adjusted earnings surpassed the Zacks Consensus Estimate. Results benefited from growth in assets under management (AUM) balance and a decline in expenses. However, lower revenues were the undermining factor.
BNY Mellon has an impressive earnings surprise history. Its earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, with a surprise of 7.4%, on average.
The Bank of New York Mellon Corporation Price and EPS Surprise
Moreover, the Zacks Consensus Estimate for the company’s first-quarter earnings of 87 cents has been revised 1.2% upward over the past seven days. However, the figure indicates a decline of 17.1% from the year-ago quarter’s reported number.
The consensus estimate for sales is pegged at $3.84 billion, indicating a 7.3% decline from the prior-year quarter’s reported figure.
Now, before we take a look at what our quantitative model predicts, let’s check the factors that are likely to have impacted BNY Mellon’s first-quarter performance.
Fee Revenues: Despite the continued concerns related to the pandemic, the first quarter witnessed overall asset inflows. Thus, driven by inflows, BNY Mellon is expected to have recorded an improvement in total AUM balance in the to-be-reported quarter.
Notably, the Zacks Consensus Estimate for the company’s total AUM is pegged at $2.22 trillion for the to-be-reported quarter, which suggests a rise of 1.1% from the previous quarter’s reported figure. Moreover, the consensus estimate for total assets under custody and administration of $41.27 trillion indicates marginal growth from the previous quarter’s reported figure.
Despite an expected increase in assets, the company’s investment management and performance fee is not likely to have improved in the quarter. The consensus estimate for the same is pegged at $873 million, suggesting a decline of 1.2% from the previous quarter’s reported number.
However, the consensus estimate for foreign exchange and other trading revenues is pegged at $171 million, suggesting a rise of 2.4% sequentially.
The consensus estimate for total investment services fee (comprising more than 50% of total revenues) of $1.99 billion indicates a 1.2% rise from the previous quarter’s reported number. Also, the consensus mark for financing-related fees is pegged at $49.56 million, which suggests a rise of 7.7% sequentially.
Thus, the consensus estimate for total fee revenues is pegged at $3.16 billion, suggesting a 1.4% rise sequentially.
Net Interest Revenues: Similar to 2020, the overall lending scenario remained weak in the first quarter due to the slow resumption of business activities. Thus, while steepening of the yield curve is likely to have offered some support to BNY Mellon’s interest income, its NIR is expected to have been hurt because of muted loan growth and the near-zero interest rate environment.
Notably, the company expects first-quarter 2021 fee waivers (net of distribution expense benefit) to be nearly $175 million.
Expenses: Because of higher litigation and restructuring charges, BNY Mellon’s expenses have been elevated over the past few years. Nevertheless, overall costs are expected to have remained manageable in the quarter, given the elimination of unnecessary management layers.
Management expects expenses (including the impact of currency) in the first quarter to be up 3-4% year over year.
What the Zacks Model Unveils
According to our quantitative model, the chances of BNY Mellon beating the Zacks Consensus Estimate this time are high. This is because it has the right combination of the two key ingredients — a positive Earnings ESP and Zacks Rank #3 (Hold) or better — which is required to increase the odds of an earnings beat.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: The Earnings ESP for BNY Mellon is +1.27%.
Zacks Rank: The company currently carries a Zacks Rank #3.
Other Stocks That Warrant a Look
Here are some other finance stocks that you may want to consider as these too have the right combination of elements to post an earnings beat in their upcoming releases, per our model.
Citigroup (C - Free Report) is slated to report quarterly results on Apr 15. The company has an Earnings ESP of +3.14% and currently carries a Zacks Rank of 3.
The Earnings ESP for Invesco (IVZ - Free Report) is +6.31% and it carries a Zacks Rank #2 (Buy) at present. The company is slated to report quarterly numbers on Apr 27.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Rise in AUM to Aid BNY Mellon's (BK) Q1 Earnings Amid Low Rates
The Bank of New York Mellon Corporation (BK - Free Report) is scheduled to report first-quarter 2021 results on Apr 16, before market open. Its revenues and earnings in the to-be-reported quarter are expected to have witnessed a decline on a year-over-year basis.
In the last reported quarter, the company’s adjusted earnings surpassed the Zacks Consensus Estimate. Results benefited from growth in assets under management (AUM) balance and a decline in expenses. However, lower revenues were the undermining factor.
BNY Mellon has an impressive earnings surprise history. Its earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, with a surprise of 7.4%, on average.
The Bank of New York Mellon Corporation Price and EPS Surprise
The Bank of New York Mellon Corporation price-eps-surprise | The Bank of New York Mellon Corporation Quote
Moreover, the Zacks Consensus Estimate for the company’s first-quarter earnings of 87 cents has been revised 1.2% upward over the past seven days. However, the figure indicates a decline of 17.1% from the year-ago quarter’s reported number.
The consensus estimate for sales is pegged at $3.84 billion, indicating a 7.3% decline from the prior-year quarter’s reported figure.
Now, before we take a look at what our quantitative model predicts, let’s check the factors that are likely to have impacted BNY Mellon’s first-quarter performance.
Fee Revenues: Despite the continued concerns related to the pandemic, the first quarter witnessed overall asset inflows. Thus, driven by inflows, BNY Mellon is expected to have recorded an improvement in total AUM balance in the to-be-reported quarter.
Notably, the Zacks Consensus Estimate for the company’s total AUM is pegged at $2.22 trillion for the to-be-reported quarter, which suggests a rise of 1.1% from the previous quarter’s reported figure. Moreover, the consensus estimate for total assets under custody and administration of $41.27 trillion indicates marginal growth from the previous quarter’s reported figure.
Despite an expected increase in assets, the company’s investment management and performance fee is not likely to have improved in the quarter. The consensus estimate for the same is pegged at $873 million, suggesting a decline of 1.2% from the previous quarter’s reported number.
However, the consensus estimate for foreign exchange and other trading revenues is pegged at $171 million, suggesting a rise of 2.4% sequentially.
The consensus estimate for total investment services fee (comprising more than 50% of total revenues) of $1.99 billion indicates a 1.2% rise from the previous quarter’s reported number. Also, the consensus mark for financing-related fees is pegged at $49.56 million, which suggests a rise of 7.7% sequentially.
Thus, the consensus estimate for total fee revenues is pegged at $3.16 billion, suggesting a 1.4% rise sequentially.
Net Interest Revenues: Similar to 2020, the overall lending scenario remained weak in the first quarter due to the slow resumption of business activities. Thus, while steepening of the yield curve is likely to have offered some support to BNY Mellon’s interest income, its NIR is expected to have been hurt because of muted loan growth and the near-zero interest rate environment.
Notably, the company expects first-quarter 2021 fee waivers (net of distribution expense benefit) to be nearly $175 million.
Expenses: Because of higher litigation and restructuring charges, BNY Mellon’s expenses have been elevated over the past few years. Nevertheless, overall costs are expected to have remained manageable in the quarter, given the elimination of unnecessary management layers.
Management expects expenses (including the impact of currency) in the first quarter to be up 3-4% year over year.
What the Zacks Model Unveils
According to our quantitative model, the chances of BNY Mellon beating the Zacks Consensus Estimate this time are high. This is because it has the right combination of the two key ingredients — a positive Earnings ESP and Zacks Rank #3 (Hold) or better — which is required to increase the odds of an earnings beat.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: The Earnings ESP for BNY Mellon is +1.27%.
Zacks Rank: The company currently carries a Zacks Rank #3.
Other Stocks That Warrant a Look
Here are some other finance stocks that you may want to consider as these too have the right combination of elements to post an earnings beat in their upcoming releases, per our model.
Citigroup (C - Free Report) is slated to report quarterly results on Apr 15. The company has an Earnings ESP of +3.14% and currently carries a Zacks Rank of 3.
BankUnited (BKU - Free Report) is scheduled to release earnings on Apr 22. The company, which carries a Zacks Rank #3 at present, has an Earnings ESP of +0.64%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Earnings ESP for Invesco (IVZ - Free Report) is +6.31% and it carries a Zacks Rank #2 (Buy) at present. The company is slated to report quarterly numbers on Apr 27.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>